ADVERTISEMENT
ADVERTISEMENT

The FDA is calling out drugmakers it says are 'gaming' the system to delay competition

The Food and Drug Administration, oversees among other things drug approvals. On Thursday, the agency published a list of 52 drugs it deemed are facing delays to getting generic versions because of "gaming" happening on the part of brand drugmakers.

  • The FDA just published a list of drugmakers the agency says are using "gaming" tactics to keep generic competition off the market.
  • The list of 52 drugs are made by some of the biggest pharmaceutical companies including Novartis, Pfizer, Mylan, and Valeant.
  • "

The FDA is calling out drugmakers it says are getting in the way of generic competition.

The Food and Drug Administration published a list on Thursday of 52 drugs it deemed are facing delays to getting generic versions because of "gaming" happening on the part of brand drugmakers.

Having generic alternatives to branded drugs is key to lowering drug prices. However, the companies that make the branded versions of the drugs stand to lose a lot of money once generic competition comes into the market.

ADVERTISEMENT

As part of the process of getting a generic alternative approved, drugmakers need to purchase samples of the branded drug. Often, the companies that make the branded version make it difficult for that to happen which slows down the process of getting that generic version on the market.

"

Last week, President Donald Trump laid out his plan to lower prescription drug prices. After the speech, FDA Commissioner Scott Gottlieb said that one of the steps the agency would be taking as part of that plan would be to address some of the "gaming" taking place around prescription drugs.

The list, which the FDA said will be updated semi-annually, names 39 major pharmaceutical and biotech companies who the agency says make it hard for generic competitors to get samples of their drugs. Those include:

ADVERTISEMENT

Celgene was down 1% Thursday after the list came out, while generic drugmakers Mylan and Teva — which also made the list from a branded-drug perspective — were up 3% and 1%, respectively.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng

Recommended articles

Here's everything to know about being a virgin on your wedding night

Here's everything to know about being a virgin on your wedding night

7 do's and don’ts of the Holy month of Ramadan

7 do's and don’ts of the Holy month of Ramadan

Top 5 sweetest celebrity mother-child relationships that stand out for us

Top 5 sweetest celebrity mother-child relationships that stand out for us

International Women's Day: 5 Nigerian female celebrities championing women’s rights

International Women's Day: 5 Nigerian female celebrities championing women’s rights

Top 5 female directors in Nollywood

Top 5 female directors in Nollywood

6 things that will break a Muslim's fast during Ramadan

6 things that will break a Muslim's fast during Ramadan

5 benefits of fasting during Ramadan

5 benefits of fasting during Ramadan

5 reasons Easter was more fun when we were children

5 reasons Easter was more fun when we were children

Dos and don’ts of supporting Muslims during Ramadan

Dos and don’ts of supporting Muslims during Ramadan

ADVERTISEMENT
ADVERTISEMENT